Skip to main content
OpenTrials
Completed

NCT Number: NCT03656276

The "ToPIC" Study = Tool to Improve Participation In Clinical Trials

The purpose of this study is to pilot the "ToPIC" tool, a communication tool to facilitate clinical trial decision making conversations between oncologists and patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Communication Behavior Physician-Patient Relations

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Wisconsin Carbone Cancer Center

Madison, Wisconsin, 53705, United States

About this study

The ToPIC tool is a structured delivery of important treatment-related information. The oncologist remains entirely in charge of the information delivered (e.g. what are the treatment options, what are the potential benefits) and uses the ToPIC framework to organize the information and create a pen and paper diagram for the patient to assist in their processing and deliberation. The tool creates a forum for a clear presentation of options and facilitates a patient's ability to express their individual preferences.

Oncologists are the intervention population and will be trained in how to use the ToPIC communication tool. Volunteer oncologists will be randomly assigned to immediate training or wait list control. Oncologists who are randomly assigned to the intervention group will receive training, and once they have demonstrated competence with the tool, they will begin using the tool with their patients. Data collection for any patient whom they present treatment options which include a clinical trial will be included for the primary analysis related to recruitment for clinical trials. This collection will begin once the oncologist, regardless of their assigned group, has signed consent and been randomized.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • (Oncologists) - All UW Health oncologists who engage with patients about treatment decisions which involve therapeutic clinical trials. Eligible oncologists may work at UW Hospital and 1 South Park and include all medical, radiation and surgical oncologists. Participation by oncologists is completely voluntary.
  • (Patients)
  • Any adults (over age 18)
  • Seen in any UW oncology clinic
  • Participated in a discussion with a participating oncologist about treatment options that included a therapeutic clinical trial.

Exclusion criteria

  • (Oncologists) ToPIC Study PI
  • (Patients) Non-English speaking patients. We exclude non-english speakers due to the unpredictable impacts of the translation/interpreter dynamic and the lack of a pen/paper diagram in the patient's native language. This would include deaf patients.
  • Blind patients (or someone who cannot see the pen/paper diagram)
  • Those who do not have capacity for decision making.
  • Those offered participation in non-therapeutic intent clinical trials. This would include Phase 1 clinical trials due to the non-therapeutic intent.

Treatment and study plan

Tool to improve Participation In Clinical Trials (ToPIC)

Behavioral

The Tool to improve Participation In Clinical Trials (ToPIC) is a communication tool to facilitate clinical trial decision making conversations between oncologists and patients.

Primary outcomes

  1. Number of patients that consent to a therapeutic trial.

    Time frame: may be up to 4 months following appointment with Oncologist

    Number of patients that consent to a therapeutic trial in the wait-list control vs. the trained oncologist groups. Per protocol, there is no timeframe within which patients need to consent. Due to the nature of oncology care, some patients are presented with the trial months before they are eligible, and the team follows up to see if they choose to consent if/when they are eligible.

Secondary outcomes

  1. Number of oncologists that can learn the ToPIC tool after 3 hours of training.

    Time frame: At completion of 3-hour training

    Oncologists will demonstrate their post-training competence with a standardized patient-actor encounter. Competency is assessed by a 4-person panel using a 20-point scoring system. A consensus score of 14 or above indicates competency.

  2. Number of patients that enroll in a therapeutic trial.

    Time frame: may be up to 6 months following consent

    Number of patients that enroll in a therapeutic trial in the wait-list control vs. the trained oncologist groups. Per protocol, there is no timeframe within which patients need to enroll. Enrollment in the trial may be prolonged due to extensive screening requirements.

  3. Number of patients that agree to hear about therapeutic trial.

    Time frame: up to 18 months

    Number of patients that agree to hear about therapeutic trial in the wait-list control vs. the trained oncologist groups. Physicians will be on study for up to 18 months once they are trained (ToPIC trained group) or enrolled (waitlist control group). The number of patients who agree to hear about the trial will be collected during the 18 month period.

Other outcomes

  1. Qualitative interviews with patients and clinicians to assess the acceptability of ToPIC conversation.

    Time frame: Within 12 weeks following oncology appointment.

    Interviews to better understand the factors that clinicians and patients consider when making treatment decisions about clinical trials and their impression of the decision making discussion.

Sponsors and collaborators

Lead sponsor

University of Wisconsin, Madison

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Sep 4, 2018
Registry last updated
Feb 11, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.